Cognoptix
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
33 Boston Post Rd W Ste 140, Marlborough...Phone Number
(508) 251-1546Website
www.cognoptix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Cognoptix
Cognoptix is a pioneering company focused on developing a non-invasive beta amyloid eye scanning test for the early detection and diagnosis of Alzheimer's Disease. Their innovative Sapphire II system allows for a simple eye scan that can be performed in a doctor's office, addressing the significant unmet need for accurate and cost-effective diagnostic methods. Co-founded by Dr. Lee Goldstein and Dr. Leo Chylack, the company aims to empower physicians and patients in managing cognitive health through early intervention. Cognoptix is actively forming strategic alliances with pharmaceutical partners and academic institutions to advance its diagnostic platform for clinical use.Explore more
Cognoptix Org Chart
CS
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cognoptix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Cognoptix, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Cognoptix has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Cognoptix had a recent Job posting/layoffs
Check out if Cognoptix is spiking on competitors!
Product Launch: Get notified when Cognoptix launches new products
Congratulate Masked Content for being promoted to Masked Content at Cognoptix
Check if Cognoptix has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Cognoptix recently announced quarterly report
Recommended Actions
Find VP level buyers at Cognoptix
Find 3 more new buyers
Compare Similar Companies to Cognoptix
Compare insights from companies similar to Cognoptix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cognoptix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cognoptix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cognoptix.
Cognoptix financials insights
Gather financial insights about Cognoptix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series A
$1M
2008
Series B
$18.5M
2011
Series C
$4.6M
2014
Debt
$390K
Series D
$15M
2020
Other Financing Round
$2.6M
Cognoptix Tech Stack
A closer look at the technologies used by Cognoptix
Most Recent Scoops
Executive Move
New Hire
Executive Move
New Hire
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Cognoptix
Sign Up For FreeTo access detailed company insights
Cognoptix is a pioneering company focused on developing a non-invasive beta amyloid eye scanning test for the early detection and diagnosis of Alzheimer's Disease. Their innovative Sapphire II system allows for a simple eye scan that can be performed in a doctor's office, addressing the significant unmet need for accurate and cost-effective diagnos... Read More
